Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,580 public trials 828 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Recruiting

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

NCT07284758

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Berenson Cancer Center West Hollywood, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Indiana University Health Indianapolis, Indiana, United States
View Trial Details
Recruiting

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

NCT06057402

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • UCI Health - Irvine Infusion Pharmacy ACC Irvine, California, United States
  • UC Irvine Health Orange, California, United States
  • UCI Health Orange, California, United States
  • UCHealth Poudre Valley Hospital Fort Collins, Colorado, United States
View all 33 locations
View Trial Details
Recruiting

A Study Assessing HMB-002 in Participants With Von Willebrand Disease

NCT06754852

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +12 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 25 locations
View Trial Details
Recruiting

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

NCT06465316

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Smilow Cancer Hospital-Derby Care Center Derby, Connecticut, United States
  • Smilow Cancer Hospital Care Center - Guilford Guilford, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 14 locations
View Trial Details
Recruiting

Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa

NCT06940830

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Sobi Investigational Site Zagreb, Croatia
  • Sobi Investigational Site Brno, Czechia
  • Sobi Investigational Site Ostrava, Czechia
  • Sobi Investigational Site Prague, Czechia
View all 29 locations
View Trial Details
Recruiting

Integrated Cancer Repository for Cancer Research

NCT02012699

Conditions
Abdominal Neoplasms, Adenoma, Adenomatous Polyposis Coli, +195 more
Locations
  • Advent Health Greenwood Village, Colorado, United States
  • Hartford HealthCare Cancer Institute at Manchester Medical Hospital Manchester, Connecticut, United States
  • Florida Hospital Memorial Medical Center Daytona Beach, Florida, United States
  • Florida Hospital DeLand DeLand, Florida, United States
View all 42 locations
View Trial Details
Recruiting

Registry of Older Patients With Cancer

NCT01137825

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +98 more
Locations
  • Seby B. Jones Cancer Center Boone, North Carolina, United States
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
  • East Carolina University Greenville, North Carolina, United States
  • Pardee Cancer Center Hendersonville, North Carolina, United States
View Trial Details

Related conditions